Wellbutrin xl and Neuroleptic malignant syndrome - from FDA reports


Summary

Neuroleptic malignant syndrome is found among people who take Wellbutrin xl, especially for people who are male, 40-49 old also take medication Seroquel, and have Drug dependence. This review analyzes which people have Neuroleptic malignant syndrome with Wellbutrin xl. It is created by eHealthMe based on reports of 12,913 people who have side effects when taking Wellbutrin xl from FDA , and is updated regularly.

What to expect?

If you take Wellbutrin xl and have Neuroleptic malignant syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Wellbutrin xl and have Neuroleptic malignant syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 24, 2017

12,913 people reported to have side effects when taking Wellbutrin xl.
Among them, 6 people (0.05%) have Neuroleptic malignant syndrome


Number of reports submitted per year:

Could Wellbutrin xl cause Neuroleptic malignant syndrome?

Gender of people who have Neuroleptic malignant syndrome when taking Wellbutrin xl *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Neuroleptic malignant syndrome when taking Wellbutrin xl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 40 %
  • 30-39: 20 %
  • 40-49: 40 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Drug Dependence (2 people, 33.33%)
  • High Blood Cholesterol (1 person, 16.67%)
  • Bipolar Disorder (1 person, 16.67%)
  • Attention Deficit Hyperactivity Disorder (1 person, 16.67%)
  • Affective Disorder (1 person, 16.67%)

Top co-used drugs for these people *:

  • Seroquel (3 people, 50.00%)
  • Vivitrol (2 people, 33.33%)
  • Prozac (2 people, 33.33%)
  • Concerta (2 people, 33.33%)
  • Abilify (2 people, 33.33%)

Top other side effects for these people *:

  • Fever (3 people, 50.00%)
  • Nausea And Vomiting (2 people, 33.33%)
  • Gastroenteritis Viral (2 people, 33.33%)
  • Drug Screen Positive (2 people, 33.33%)
  • Agitation (2 people, 33.33%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Neuroleptic malignant syndrome when taking Wellbutrin xl?

Expand the study to include all drugs with the same ingredients

Neuroleptic malignant syndrome and drugs with ingredients of bupropion hydrochloride.

Expand the study to include reports from both FDA and eHealthMe

Neuroleptic malignant syndrome and Wellbutrin xl from FDA and eHealthMe reports

Wellbutrin xl

Wellbutrin xl has active ingredients of bupropion hydrochloride. It is often used in depression. (latest outcomes from Wellbutrin xl 17,017 users)

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents) has been reported by people with schizophrenia, depression, bipolar disorder, psychotic disorder, parkinson's disease (latest reports from 9,926 Neuroleptic malignant syndrome patients).

Browse all side effects of Wellbutrin xl

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Could your condition cause Neuroleptic malignant syndrome

Neuroleptic malignant syndrome

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Wellbutrin xl and have Neuroleptic malignant syndrome.

Questions to the study

More questions >

User reviews to the study

More reviews >